A secondary endpoint of non-inferior levels of trastuzumab was also met, with blood concentrations for people receiving Phesgo non-inferior to those receiving IV trastuzumab (GMR=1.33 [90 per cent ...

Basel, 30 April 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion ...

The manufacturer recommends an initial trastuzumab dose of 4 mg/kg i.v. over 90 minutes, followed by a weekly maintenance dose of 2 mg/kg i.v. administered over 30 minutes if the initial dose is ...

Quebec's government said Friday that it would also pay for Herceptin for early stage breast cancer when the drug is given in hospital. British Columbia was the first to pay for the drug.

CHICAGO — Trastuzumab deruxtecan plus pertuzumab showed significant improvement in PFS compared with taxane chemotherapy plus trastuzumab and pertuzumab across patients with HER2-positive ...

Adverse events related to the use of trastuzumab injection should be reported to the FDA's MedWatch program by phone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, online at https://www.fda.gov ...